CD Diagnostics
Claymont, Delaware, United States
About CD Diagnostics
CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists who would like greater diagnostic confidence in joint fluid analysis. Unlike current technologies, which often yield vague and ambiguous results, CygnaSure™, our lead product, offers orthopaedic surgeons and rheumatologists a rapid, accurate and reliable diagnostic answer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: M&A
- Last round: Series A (Sep 2012)
- Website: cddiagnostics.com
- Phone: 4844764801
Industries & Categories
Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/cd-diagnostics-2468642 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.